Royal Philips

Koninklijke Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. It operates through the following segments: Diagnosis and Treatment businesses; Connected Care businesses; Personal Health businesses; and Other. The Diagnosis and Treatment businesses segment consists systems, smart devices, software and services, powered by AI-enabled informatics-that support precision diagnoses and minimally invasive procedures in therapeutic areas such as cardiology, peripheral vascular, neurology, surgery, and oncology. The Connected Care businesses segment consists Hospital Patient Monitoring, Emergency Care, Sleep & Respiratory Care and Connected Care Informatics. The Personal Health businesses segment consists of Oral Healthcare, Personal Care,Mother and Child Care. The Other segment reports on the items Innovation & Strategy, IP Royalties, Central costs, and other small items. The company was founded by Anton Frederik Philips and Gerard Leonard Frederik Philips in 1891 and is headquartered in Amsterdam, the Netherlands.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Koninklijke Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. It operates through the following segments: Diagnosis and Treatment; Connected Care; Personal Health; and Other. The Diagnosis and Treatment segment consists of systems, smart devices, software, and services, powered by AI-enabled solutions that support precision diagnoses and minimally invasive treatment in therapeutic areas such as cardiology, peripheral vascular, neurology, surgery, and oncology. The Connected Care segment focuses on Hospital Patient Monitoring, Sleep and Respiratory Care, and Enterprise Informatics. The Personal Health segment represents Oral Healthcare business unit, Personal Care business unit, and Mother and Child Care business unit. The Other segment is involved on the Innovation and Strategy, IP Royalties, Central costs, and other small items. The company was founded by Anton Frederik Philips and Gerard Leonard Frederik Philips in 1891 and is headquartered in Amsterdam, the Netherlands.

When investors think of Philips, they think of an industrial conglomerate with operations across hundreds of various areas and segments. That was once the case - but it is no longer what Philips intends, nor what it currently is.

Philips: Maybe Not What You Think, But Interesting

Philips announces first patient treated with its new real-time 3D intracardiac echocardiography catheter – VeriSight Pro

Koninklijke Philips (PHG) has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock.

Koninklijke Philips (PHG) is Oversold: Can It Recover?

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that Children's Hospital & Medical Center, one of U.S. News and World Report's Best Children's Hospitals, is adopting a full suite of Philips cloud-based enterprise imaging informatics solutions across radiology, cardiology and subspecialties as part of their ongoing pursuit of quality patient care and improved outcomes. These solutions will provide advanced visuali

Children's Hospital & Medical Center Adopts Innovative Philips Cloud-Based Enterprise Imaging Solution to Advance Precision Diagnosis

Philips and the Spanish National Center for Cardiovascular Research (CNIC) collaborate on a new ultra-fast cardiac MRI protocol for research purposes with the aim of benefitting clinical practice in the future

New York, New York--(Newsfile Corp. - June 26, 2021) - Pomerantz LLP is investigating claims on behalf of investors of Koninklijke Philips N.V. ("Philips" or the "Company") (NYSE: PHG). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.The investigation concerns whether Philips and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about...

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Koninklijke Philips N.V. - PHG

LOS ANGELES--(BUSINESS WIRE)---- $PHG #CLASSACTION--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Koninklijke Philips N.V. (“Philips” or the “Company”) (NYSE: PHG) investors concerning the Company's possible violations of the federal securities laws. If you suffered a loss on your Philips investments or would like to inquire about potentially pursuing claims to recover your loss under the federal securities

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Koninklijke Philips N.V. (PHG) on Behalf of Investors

Philips announces first patient enrollment in DEFINE GPS global multicenter study to assess superiority of PCI procedures guided by co-registered iFR and interventional angiography

BENSALEM, Pa.--(BUSINESS WIRE)---- $PHG #CLASSACTION--Law Offices of Howard G. Smith announces an investigation on behalf of Koninklijke Philips N.V. (“Philips” or the “Company”) (NYSE: PHG) investors concerning the Company's possible violations of federal securities laws. On April 26, 2021, Philips announced its first quarter 2021 financial results and reported a EUR 250 million provision for “a quality issue in a component that is used in certain sleep and respiratory care products.” Specifically, the Company reve

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Koninklijke Philips N.V.

LOS ANGELES--(BUSINESS WIRE)---- $PHG #investors--The Law Offices of Frank R. Cruz Continues Investigation of Koninklijke Philips N.V. (PHG) on Behalf of Investors

The Law Offices of Frank R. Cruz Continues Investigation of Koninklijke Philips N.V.

LOS ANGELES--(BUSINESS WIRE)---- $PHG #investors--The Law Offices of Frank R. Cruz Announces Investigation of Koninklijke Philips N.V. (PHG) on Behalf of Investors

The Law Offices of Frank R. Cruz Announces Investigation of Koninklijke Philips N.V.

NEW YORK, June 16, 2021 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Koninklijke Philips ("Philips" or "the Company") (NYSE: PHG). Investors who purchased Philips securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: www.bgandg.com/phg.

Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Koninklijke Philips (PHG) Investigation

ResMed

The full U.S. launch of ResMed (RMD) AirSense 11 is expected any time in 2021, which might receive bigger market acceptance capitalizing on its current peer position.

ResMed (RMD) Rallies as Philips Falters on Mass Product Recall

The Dutch medical equipment firm Koninklijke Philips NV (OTC: RYLPF) has recalled several of its sleep apnea and respiratory care devices due to potential health risks. What Happened: The company stated that its Bi-Level Positive Airway Pressure (Bi-Level PAP), Continuous Positive Airway Pressure (CPAP), and mechanical ventilator devices are being recalled because of the polyester-based polyurethane (PE-PUR) sound abatement foam component used in the devices within the DreamStation product line.

Philips Recalls Ventilators And Sleep Apnea Devices Due To Possible Health Risks

Philips (PHG) is recalling some Bi-Level PAP, CPAP, and mechanical ventilator devices in the United States due to health risks.

Philips (PHG) Recalls CPAP, Ventilators Used for Sleep Apnea

Philips is recalling millions of devices — including sleep apnea machines and ventilators used for coronavirus patients — over concerns that a component could cause cancer, the company said Monday.

Philips sleep apnea devices recalled over potential cancer risks

The company, which is the largest maker of such machines, is recalling faulty devices that could potentially be toxic to users.

Philips Recalls Up To 4 Million Ventilators And Breathing Machines, Including Some Listed As Respiratory Treatments For Covid-19

Philips, the Dutch medical equipment company, on Monday said it would recall ventilators and "CPAP" breathing devices globally because of a foam part that might degrade and be inhaled.

Philips recalls some 3-4 million "CPAP", ventilator machines due to foam part

Philips issues recall notification* to mitigate potential health risks related to the sound abatement foam component in certain sleep and respiratory care devices

Philips announces exchange ratio for 2020 dividend

Philips highlights integrated informatics solutions at virtual HIMSS & Health 2.0 European Health Conference 2021

June 7, 2021 Healthcare leaders partner to streamline the path from cancer diagnosis to survivorship for better outcomes

Philips and Elekta deepen strategic partnership in precise and individualized oncology care

Two-year data from the TOBA II BTK clinical trial demonstrate durability of dissection repair below the knee with the Philips Tack Endovascular System

Philips and Akumin partner to advance radiology performance and quality, and reimagine radiology network ecosystems

Philips to provide Spanish Viamed hospital group with advanced diagnostic imaging solutions

News for Royal Philips Stock (PHG)